Task force III: Target-organ damage, morbidity and mortality

Blood Pressure Monitoring

Volumn 4, Issue 6, 1999, Pages 303-317

  Verdecchia, Paolo ^a   Clement, Denis ^b   Fagard, Robert ^c   Palatini, Paolo ^d   Parati, Gianfranco ^e  

^a Ospedale Silvestrini   (Italy)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

^d UNIVERSITY OF PADOVA   (Italy)

^e ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Ambulatory blood pressure monitoring; Antihypertensive therapy; Hypertension; Prognosis

Indexed keywords

AMBULATORY MONITORING; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CONFERENCE PAPER; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; HEART LEFT VENTRICLE MASS; HUMAN; MORBIDITY; MORTALITY; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; STANDARDIZATION; SYMPOSIUM; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TARGET ORGAN; VARIANCE; BLOOD PRESSURE; CEREBROVASCULAR DISEASE; CONSENSUS DEVELOPMENT; DAILY LIFE ACTIVITY; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; INSTRUMENTATION; MENTAL STRESS; METHODOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; STANDARD; TIME;

ACTIVITIES OF DAILY LIVING; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CEREBROVASCULAR DISORDERS; CIRCADIAN RHYTHM; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MORBIDITY; PROGNOSIS; REPRODUCIBILITY OF RESULTS; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 0033254659     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126097-199912000-00004     Document Type: Conference Paper

References (106)

1. Krakoff LR, Ambulatory blood pressure monitoring can improve costeffective management of hypertension. Am J Hypertens 1993; 6:20S-224S.
2. American College of Physicians. Automated ambulatory blood pressure and self-measured blood pressure monitoring devices: their role in the diagnosis and management of hypertension. Ann Intern Med 1993; 118:889-892.
3. Perloff D, Sokolow M. Cowan R. The prognostic value of ambulatory blood pressure. JAMA 1983; 249:2792-2798.
4. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 1994; 24:793-801.
5. Zweiker R, Eber B, Schumacher M, Toplak H, Klein W. 'Non-dipping1 related to cardiovascular events in essential hypertensive patients. Ada MedAustriaca 1994; 21:86-89.
6. Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato K, Kikuchi N, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure: a population-based observation in Ohasama, Japan. J Hypertens 1998; 16:971-975.
7. Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension. A prospective study. Hypertension 1998; 31:712-718.
8. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10 year follow-up study. Circulation 1998;98:1982-1987.
9. Yamamoto Y, Akiguchi I, Oiwa K, Hayashi M, Kimura J. Adverse effect of nighttime blood pressure on the outcome of lacunar infarct patients. Stroke 1998;29:570-576.
10. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, e( a/, for the Systolic Hypertension in Europe (Syst-Eur) trial investigators. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999; 282:539-546.
11. Winnicki M, Canali C, Mormino P, Palatini P. Ambulatory blood pressure monitoring editing criteria: is a standardization needed? Am J Hypertens 1997; 10:419-427.
12. Fagard R, Staessen J, Thijs L, Amery A. Multiple standardized clinic blood pressures may predict left ventricular mass as well as ambulatory monitoring. Am J Hypertens 1995; 8:533-540.
13. Fagard RH, Staessen JA, Thijs L Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. Hypertension 1997;29:22-29.
14. Mancia G, Di Rienzo M, Parati G. Ambulatory blood pressure monitoring use in research and clinical practice. Hypertension 1993; 24:510-524.
15. Pickering TG, James G D, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA 1988; 259:225-228.
16. Stewart MJ, Padfield PL Blood pressure measurement: an epitaph for the mercury sphygmomanometer? Clin Sei 1993; 83:1-12.
17. Mancia G, Gamba PL, Omboni S, Paleari F, Parati G, Sega R, ef aJ. Ambulatory blood pressure monitoring. J Hypertens 1996; 14 (suppl 2):S61-S68.
18. Guidelines Subcommittee. 1999 WHO/ISH guidelines for the management of hypertension. J Hypertens 1999; 17:151-183.
19. Rowlands DB, Glover DR, Ireland MA, McLeay RAB, Stallard TJ, Watson RDS, ef al. Assessment of left-ventricular mass and its response to antihypertensive treatment. Lancet 1982; i:467-470.
20. Devereux RB, Pickering TG, Harshfield GA, Kleinen HD, Denby I, Clark L, et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation 1983; 68:470-476.
21. Palatini P, Mormino P, DiMarco A, Libardoni M, Mos L, Munari L, er al. Ambulatory blood pressure versus casual pressure for the evaluation of target organ damage in hypertension: complications of hypertension. J Hypertens 1985; 3 (suppl 3):S425-S427.
22. White WB, Schulman P, Dey HM, Katz AM. Effects of age and 24-hour ambulatory blood pressure on rapid left ventricular filling. Am J Cardiol 1989;63:1343-1347.
23. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81:528-536.
24. Fagard R, Bielen E, Amery A. Automated versus observer blood pressure as determinants of left ventricular structure. Eur Heart J 1992; 13:1373-1379.
25. Gosse P, Promax G, Durandet P, Clementy J. 'White coat1 hypertension. No harm for the heart. Hypertension 1993; 22:766-770.
26. Hoegholm A, Kristensen KS, Band LE, Nielsen JW, Madsen NH. Left ventricular mass and geometry in patients with established hypertension and white coat hypertension. Am J Hypertens 1993; 6:282-286.
27. Kuwajima I, Suzuki Y, Fujisawa A, Kuramoto K. Is white coat hypertension innocent? Structure and function of the heart in the elderly. Hypertension 1993:22:826-831.
28. Trenkwalder P, Plaschke M, Steffes-Tremer I, Lydtin H. 'White coat' hypertension and alerting reaction in elderly and very elderly. Blood Press 1993:2:262-271.
29. Cavallini MC, Roman MJ, Pickering TG, Schwartz JE, Pini R. Devereux RB. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy? Hypertension 1995; 26:413-419.
30. Cuspidi C, Marabini M, Lonati L, Sampieri L, Comerio G, Pelizzoli S, et al. Cardiac and carotid structure in patients with established hypertension and white coat hypertension. J Hypertens 1995; 13:1707-1711.
31. Pierdomenico SD, Lapenna D, Guglielmi MD, Antidormi T, Schiavone C, Cuccurullo F, et al. Target organ status and serum lipids in patients with white coat hypertension. Hypertension 1995; 26:801-807.
32. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Zampi I, Gattobigio R, et al. White coat hypertension and white coat effect. Similarities and differences. Am J Hypertens 1995; 8:790-798.
33. Glen SK, Elliott HL, Curzio JL, Lees KR, Reid JL. White-coat hypertension as a cause of cardiovascular dysfunction. Lancet 1995; 348:654-657.
34. Pose-Reino A, Gonzalez-Juanatey JR, Pastor C, Mendez I, Estevez JC, Alvarez D, ef aJ. Clinical implications of white coat hypertension. Blood Press 1996; 5:264-273.
35. Rizzo V, Cicconetti P, Blanchi A, Lorido A, Morelli S, Vetta F, et al. Whitecoat hypertension and cardiac organ damage in elderly subjects. J Hum Hypertens 1996; 10:293-298.
36. Hoegholm A, Kristansen KS, Bang LE, Nielsen JW. White coat hypertension and target organ involvement: the impact of different cut-off levels on albuminuria and left ventricular mass and geometry. J Hum Hypertens 1998; 12:433-439.
37. Verdecchia P, Schillaci G, Boldrini F, Zampi I, Porcellati C. Variability between current definitions of 'normal1 ambulatory blood pressure. Implications in the assessment of white-coat hypertension. Hypertension 1992:20:555-562.
38. Owens PE, Lyons SP, Rodriguez SA, O'Brien ET. Is elevation of clinic blood pressure in patients with white coat hypertension who have normal ambulatory blood pressure associated with target organ damage? J Hum Hypertens 1998; 12:743-748.
39. Palatini P, Mormino P, Santonastaso M, Mos L, Dal-Follo M, Zanata G, et al. Target organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. Hypertension 1998; 31:57-63.
40. Asmar RG, Brunei PC, Pannier BM, Lacolley PJ, Safar ME. Arterial distensibility and ambulatory blood pressure monitoring in essential hypertension. Am J Cardiol 1988; 61:1066-1070.
41. Redon J, Mirailes A, Liao Y, Lozano JV, Pascual JM, Cooper RS. Circadian variability and microalbuminuria in essential hypertension. J Hypertens 1994; 12:947-954.
42. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese V. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 1994; 7:23-29.
43. Joint national committee on detection, evaluation, and treatment of high blood pressure. The sixth report of the joint national committee on the detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157:2413-2446.
44. Palatini P, Mormino P, Santonastaso M,- Mos L, Pessina AC. Ambulatory blood pressure predicts end-organ damage only in subjects with reproducible recordings. J Hypertens 1999; 17:465-474.
45. Des Combes BJ, Porchet M, Waeber B, Brunner HR. Ambulatory blood pressure recordings. Reproducibility and unpredictability. Hypertension 1984; 6:110-114.
46. Verdecchia P, Schillaci G, Boldrini F, Guerrieri M, Zampi I, Porcellati C. Quantitative assessment of day-to-day spontaneous variability in noninvasive ambulatory blood pressure measurements in essential hypertension. J Hypertens 1991 ; 9 (suppl 6):S322-S323.
47. Mancia G, Zanchetti A, Agabiti Rosei E, Benemio G, De Cesaris R, Fogari R, et al. for the SAMPLE study group. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression . of left ventricular hypertrophy. Circulation 1997; 95:1464-1470.
48. Fagard RH, Staessen JA, Thijs L The relationship between left ventricular mass and daytime and night-time blood pressures: a meta-analysis of comparative studies. J Hypertens 1995; 13:823-829.
49. Fagard RH, Staessen JA, Thijs L. Relationship between changes in left ventricular mass and in clinic and ambulatory pressure in response to antihypertensive therapy. J Hypertens 1997; 15:1493-1502.
50. Verdecchia P, Schillaci G, Boldrini F, Guerrieri M, Porcellati C. Sex, cardiac hypertrophy and diurnal blood pressure variations in essential hypertension. J Hypertens 1992; 10:683-692.
51. Breteler MMB, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JHW, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam study. Neurology 1994; 44:1246-1252.
52. Longstreth WT, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, ef aJ. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the Cardiovascular Health Study. Stroke 1996; 27:1274-1282.
53. Liao D, Cooper L, Jianwen C, Toole JF, Bryan NR, Hutchinson RG, et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment and its control: the ARIC study. Stroke 1996; 27:2262-2270.
54. Goldstein IB, Bartzokis G, Hance DB, Shàpiro D. Relationship between blood pressure and subcortical lesions in healthy elderly people. Stroke 1998; 29:765-772.
55. Kawamoto A, Shimada K, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T. Factors associated with silent lacunar lesion in magnetic resonance imaging in asymptomatic elderly hypertensive patients. Clin Exp Pharmacol Physio/1991; 18:605-610.
56. Shimada K, Kawamoto A, Matsubayashi K, Ozawa T. Silent cerebrovascular disease in the elderly: correlation with ambulatory pressure. Hypertension 1990; 16:692-699.
57. Watanabe N, Imai Y, Nagai K, Tsuji I, Satoh H, Sakuma M, el aJ. Nocturnal blood pressure and silent cerebrovascular lesions in elderly Japanese. Stroke 1996; 27:1319-1327.
58. Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 1992; 10:875-878.
59. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Hypertension 1996; 27:130-135.
60. Kario K, Eguchi K, Nakagawa Y, Motai K, Shimada K. Relationship between extreme dippers and orthostatic hypertension in elderly hypertensive patients. Hypertension 1998; 31:77-82.
61. Kohara K, Igase M, Yinong J, Fukuoka T, Maguchi M, Okura T, ef aJ. Asymptomatic cerebrovascular damage in essential hypertension in the elderly. Am J Hypertens 1997; 10:829-835.
62. Morfis L, Howes LG. Nocturnal fall in blood pressure in the elderly is related to presence of hypertension and not age. Blood Press 1997; 6:274-278.
63. Bidlingmeyer I, Burnier M, Bidlingmeyer M, Waeber B, Brunner HR. Isolated office hypertension: a prehypertensive state? J Hypertens 1996; 14:327-332.
64. Palatini P, Dorigatti F, Roman E, Giovinazzo P, Piccolo D, De Venuto G, et aJ. White-coat hypertension: a selection bias? J Hypertens 1998; 16:977-984.
65. Palatini P, Mormino P, Dorigatti F, Roman E, Frigo G, Piccolo D, ef aJ. Predictive value of ambulatory blood pressure for the development of sustained hypertension. A 5-year follow-up of the HARVEST study. J Hypertens 1999; 17 (suppl 3):S15.
66. Mancia G, Parati G, Di Rienzo M, Zanchetti A. Blood pressure variability. In: Zanchetti A, Mancia G. (editors): Handbook of hypertension Volume 17. Pathophysiology of hypertension. New York: Elsevier Science Ltd; 1997. pp. 117-169.
67. Bevan AT, Honour AJ, Stott FH. Direct arterial pressure recording in unrestricted man. Clin Sei 1969; 36:329-344.
68. Mancia G, Bertinieri G, Parati G, Pomidossi G, Ferrari A, Gregorini L, ef aJ. Effects of blood pressure measurement by the doctor on patients' blood pressure and heart rate. Lancet 1983; ii:695-698.
69. Mancia G, Parati G, Pomidossi G, Grassi G, Casadei R, Zanchetti A. Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension 1987; 9:209-215.
70. Parati G, Saul JP, Di Rienzo M, Mancia G. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. Hypertension 1995; 25:1276-1286.
71. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, ef aJ. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 1983; 53:96-104.
72. Di Rienzo M, Grassi G, Pedotti A, Mancia G. Continuous vs intermittent blood pressure measurements in estimating 24-hour average blood pressure. Hypertension 1983; 5:264-269.
73. Parati G, Di Rienzo M, Omboni S, Castiglioni P, Frattola A, Mancia G. Spectral analysis of 24h blood pressure recordings. Am J Hypertens 1993; 6:1883-1933.
74. Pickering TG. Ambulatory blood pressure monitoring. London: Science Press; 1991.
75. Imholz BPM, Wieling W, Langewouters G, Van Montfrans G A. Continuous finger arterial pressure: utility in the cardiovascular laboratory. Clin Auton Res 1991; 1:43-53.
76. Parati G, Casadei R, Groppelli A, Di Rienzo M, Mancia G. Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension 1989; 13:647-655.
77. Imholz BPM, Langewouters GJ, van Montfrans GA, Parati G, van Goudoever J, Wesseling KH, ef aJ. Feasibility of ambulatory, continuous 24-hour finger arterial pressure recording. Hypertension 1993; 21:65-73.
78. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target organ damage in hypertension. J Hypertens 1987; 5:93-98.
79. Palatini P, Penzo M, Racioppa A, Zugno E, Guzzardi G, Anaclerio M. Clinical relevance of night-time blood pressure and of day-time blood pressure variability. Arch Intern Wed 1992; 152:1855-1860.
80. Rocco MB, Nadel EG, Slevyn AP. Circadian rhythms and coronary artery disease. Am J Cardiol 1987; 59:13C-17C.
81. Parati G, Omboni S, Di Rienzo M, Frattola A,'AIbini F, Mancia G. Twentyfour hour blood pressure variability: clinical implications. Kidney /nf 1992; 41 (suppl 37):S24-S28.
82. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens 1993; 11:1133-1137.
83. Sasaki S, Yoneda Y, Fujita H, Uchida A, Takenaka K, Takesako T, et al. Association of blood pressure variability with induction of atherosclerosis in cholesterol-fed rats. Am J Hypertens 1994; 7:453-459.
84. Verdecchia P, Borgioni C, Ciucci A, Gattobigio R, Schillaci G, Sacchi N, ef aJ. Prognostic significance of blood pressure variability in essential hypertension. Univariate and multivariat'e assessment. Blood Press Monit 1996; 1:3-11.
85. Omboni S, Parati G, Frattola A, Mutti E, Di Rienzo M, Castiglioni P, et al. Spectral and sequence analysis of finger blood pressure variability: comparison with analysis of intra-arterial recordings. Hypertension 1993; 22:26-33.
86. Omboni S, Parati G, Castiglioni P, Di Rienzo M, Imholz BPM, Langewouters G, et al. Estimation of blood pressure variability from 24hour ambulatory finger blood pressure. Hypertension 1998; 32:52-58.
87. Pickering TG, James G D. Ambulatory blood pressure and prognosis. J Hypertens 1994; 12 (suppl 8):S29-S33.
88. Clement DL, De Buyzere M, Duprez D. Ambulatory blood pressure and prognosis: summary of ongoing studies. J Hypertens 1991 ; 9 (suppl 8):S51-S53.
89. Zanchetti A, Bond G, Henning M, Neiss A, Mancia G, Dal Palù C, er al. on behalf of the ELSA investigators. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens 1988; 16:949-961.
90. Brown MJ, Castaigne A, Ruilope LM, Mancia G, Rosenthal T, de Leeuw PW, et al. INSIGHT: international nifedipine GITS study intervention as a goal in hypertension treatment. J Hum Hypertens 1996; 10 (suppl 3):S157-S160.
91. Imai Y, Ohkubo T, Tsuji I, Nagai K, Satoh H, Hisamichi S, et al. Prognostic value of ambulatory and home blood pressure measurements in comparison to screening blood pressure measurements: a pilot study in Ohasama. Blood Press Monit 1996; 1 (suppl 2):S51-S58.
92. Ohkubo T, Imai Y, Tsuji I, Nagai K, Watanabe N, Minami N, ef aJ. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens 1997:15:357-364.
93. Perloff D, Sokolow M, Cowan RM, Juster RP. Prognostic value of ambulatory blood pressure measurements: further analyses. J Hypertens 1989; 7 (suppl 3):S3-S10.
94. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C. White-coat hypertension, tancef 1996; 348:1444-1445.
95. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Porcellati C. Nocturnal pressure is the true pressure. Blood Press Monit 1996; 1 (suppl 2):S81-S85.
96. Khattar RS, Parsons A, Kinsey C, Senior R, Lahiri A. Ambulatory systolic blood pressure is superior to clinic measurement for the prediction of future cardiovascular events in essential hypertension: a 10-year follow-up study [abstract]. Circulation 1998; 96:1337.
97. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Pede S, Porcellati C. Ambulatory pulse pressure. A potent predictor of total cardiovascular risk in hypertension. Hypertension 1993; 32:983-988.
98. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C. Prognostic significance of the white-coat effect. Hypertension 1997; 29:1218-1224.
99. Ohkubo T, Imai Y, Tsuji I, Nagai K, Watanabe N, Minami N, ef aJ. Relation between nocturnal decline in blood pressure and mortality. The Ohasama study. Am J Hypertens 1997; 10:1201 -1207.
100. Nakano S, Fukuda M, Hotta F, Ito T, Ishii T, Kitazawa M, et al. Reversed circadian blood pressure rhythm is associated with occurrence of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes 1998; 47:1501-1506.
101. Fagard R, Brguljan J, Thijs L, Staessen J. Prediction of the actual awake and asleep blood pressures by various methods of 24h pressure analysis. J Hypertens 1996; 14:557-563.
102. Sobrino J, Ribera L, Adrian MJ, Soler J, Pladevall M, Felip A, et aJ. Reproducibility of the circadian blood pressure profile in essential hypertension [abstract]. J Hypertens 1999; 17 (suppl 3):S22.
103. de Simone G, Muiesan ML, Ganau A, Longhini C, Verdecchia P, Palmieri V, et a/, on behalf of the working group on heart and hypertension of the Italian Society of Hypertension. Test-retest reliability of measurements of left ventricular mass in single patients: the Reproducibility Echocardiographic Study (RES). J Hypertens 1999; (in press).
104. Ramsay LE, Williams B, Johnston GD, MacGregor GA, Poston L, Potter JF, ef aJ. British Hypertension Society guidelines for hypertension management 1999: summary. BMJ 1999; 519:630-635.
105. Pickering TG, for an American Society of Hypertension ad hoc panel. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 1995; 9:1-11.
106. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, et aJ. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 1995; 13:1377-1390.